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Proline pre-conditioning of cell monolayers
increases post-thaw recovery and viability by
distinct mechanisms to other osmolytes†‡
Trisha L. Bailey, a Juan Ramon Hernandez-Fernaud b and Matthew I. Gibson *ac
Cell cryopreservation is an essential tool for drug toxicity/function screening and transporting cell-based
therapies, and is essential in most areas of biotechnology. There is a challenge, however, associated with
the cryopreservation of cells in monolayer format (attached to tissue culture substrates) which gives far
lower cell yields (<20% typically) compared to suspension freezing. Here we investigate the mechanisms
by which the protective osmolyte L-proline enhances cell-monolayer cryopreservation. Pre-incubating
A549 cells with proline, prior to cryopreservation in monolayers, increased post-thaw cell yields two-fold,
and the recovered cells grow faster compared to cells cryopreserved using DMSO alone. Further increases
in yield were achieved by adding polymeric ice recrystallization inhibitors, which gave limited benefit in the
absence of proline. Mechanistic studies demonstrated a biochemical, rather than biophysical (i.e. not
affecting ice growth) mode of action. It was observed that incubating cells with proline (before freezing)
transiently reduced the growth rate of the cells, which was not seen with other osmolytes (betaine and
alanine). Removal of proline led to rapid growth recovery, suggesting that proline pre-conditions the cells
for cold stress, but with no impact on downstream cell function. Whole cell proteomics did not reveal a
single pathway or protein target but rather cells appeared to be primed for a stress response in multiple
directions, which together prepare the cells for freezing. These results support the use of proline alongside
standard conditions to improve post-thaw recovery of cell monolayers, which is currently considered
impractical. It also demonstrates that a chemical biology approach to discovering small molecule
biochemical modulators of cryopreservation may be possible, to be used alongside traditional (solvent)
based cryoprotectants.
Introduction
The storage, recovery, and manipulation of viable cells is the
key component of all cell biology research, with primary cells
being the most rare/valuable, and stem cells are currently
emerging for many personalized medical treatments.1,2 Cell
cryopreservation can give variable results with the phenotypic
impact of frozen/thawed cells still unknown in many cases.
Standard protocols use 5–10 wt% of the cryoprotective agent
(CPA) dimethyl sulfoxide (DMSO), which is able to enter cells
and reduce injury by moderating the increase in solute
concentration during freezing.3–5 While suspension freezing
in DMSO is highly successful, certain cells such as leukocytes
(RAW 264.7) are highly-sensitive to DMSO.6 Additionally, there
are some concerns with using DMSO due to its cytotoxicity at
high concentrations and/or room temperature.7–11 Freezing
with DMSO is the gold standard for suspension cell
cryopreservation in nearly every research laboratory but the
method does not work well for cell monolayers,12 typically
resulting in only around 20–35% recovery, often even
lower.13,14 For example, adherent human embryonic stem
cells yield extremely low survival rates of <5%.12,13 The ability
to cryopreserve monolayered cells would facilitate drug
development by providing phenotypically identical cells for
assays, reduce the total resource needed for cell culture (e.g.
cells are already in format for assay) as well as providing
insights into the cryopreservation of more complex biological
material such as spheroids or tissues.
According to Mazur's two-factor hypothesis, key challenges
in cryopreservation are ice formation and osmotic stress due
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to the addition of cryoprotective agents and the increasing
concentration of solutes in the remaining water phase during
the freezing process.15,16 Intracellular ice can form when the
cooling rate is intermediately high and the cell cannot
maintain osmotic equilibrium with the environment, and is
almost always lethal.17,18 Controlled-rate freezing ensures
movement of water across the plasma membrane in order for
osmotic dehydration to reach equilibrium with intracellular
and extracellular contents to prevent intracellular ice.19,20
During thawing, ice recrystallization can damage the cells by
both mechanical and osmotic stress, and controlling this
process by using ice recrystallization inhibitors (IRIs) has
been shown to result in enhanced post-thaw recovery.21,22
Antifreeze (glyco)proteins (AF(G)Ps) are potent IRIs and can
reduce damage to cell membranes,23–25 however, AF(G)Ps are
unsuitable for cryopreservation applications due to their
potential toxicity/immunogenicity, their secondary effect of
dynamic ice shaping (DIS),21 and their low availability/
expense. Considering this, there is significant interest in the
discovery of AF(G)P mimics.21,26–28
The most studied IRI active polymer is poly(vinyl alcohol)
(PVA), due to its potent IRI, low toxicity, and commercial
availability.24,29,30 PVA gives some benefit to the
cryopreservation of cells in suspension,31–33 but has not been
explored for cell monolayer cryopreservation, although
polyproline (a weak IRI) was reported to enhance monolayer
recovery when used in conjunction with the protective
osmolyte proline34 and has been applied to oocytes also.35
Without addition of proline, there was limited benefit of the
IRI-active polymer, but the functional role of this proline
incubation is not fully understood.
Cells almost universally respond to the stress of long-term
hyperosmolality, such as during freezing, by accumulating
compatible organic osmolytes.36 The major osmolytes in
water-stressed eukaryotes include metabolic products such as
glycerol and sucrose, amino acids (plus derivatives such as
taurine and β-alanine), urea, and methylamines (e.g. tri-
methylamine-N-oxide).37 The most widely studied
‘compatible’ solutes are the N-substituted amino acids,
particularly betaine and proline.38 Betaine's osmoprotection
has been widely observed, such as in the dogfish shark
Squalus acanthias promoting betaine efflux during hypotonic
conditions.39 Betaine reduces leakage from frozen
multilamellar liposomes,40 and can enhance the vitrification
of mammalian cells in suspension.41 Proline is membrane
permeable regardless of pH,42 and transfer can occur by a
range of processes.43 Proline has been implicated as a
survival factor that protects the cell against apoptosis and
maintains the progression of the cell cycle through a signal
recognition function of the transporters that may take part in
the control of cell cycle progression and programmed cell
death.44 Proline has been used with success to cryopreserve
mouse oocytes,45 vitrify red blood cells (RBCs) and
mammalian cells,46 induce freeze-tolerance in fruit fly
larvae,47 and has shown protection for mammalian cell
monolayers when used alongside trehalose.14
Considering the above, this study explores the use of
proline for the cryopreservation of adherent cell monolayers
in comparison to other protective osmolytes. It is shown that
incubation of cell monolayers with proline, in advance of
cryopreservation, leads to increases in post-thaw recovery.
Addition of polymeric IRIs further increased the post-thaw
cell yield, but only when used with proline, not without.
Evidence is presented that proline prepares the cells for
freezing by a temporary slowing of cellular growth which was
not seen for other osmolytes and may explain its beneficial
role in cell monolayer cryopreservation.
Experimental section
Cell culture
Reagents and solution preparation. PVA (Mw 9000–10 000,
80% hydrolysed), proline, alanine and betaine were obtained
from Sigma Aldrich Co Ltd, (Irvine, UK). Solutions for cell
experiments were prepared by dissolving the individual
compounds in base cell media supplemented with 10% FBS
and 1× PSA (solutions used as CPAs did not contain PSA) and
sterile filtering prior to use.
A549 cell culture. Human Caucasian lung carcinoma cells
(A549) were obtained from the European Collection of
Authenticated Cell Cultures (ECACC) (Salisbury, UK) and
grown in 175 cm2 cell culture Nunc flasks (Corning
Incorporated, Corning, NY). Standard cell culture medium
was composed of Ham's F-12K (Kaighn's) Medium (F-12K)
(Gibco, Paisley, UK) supplemented with 10% USA-origin fetal
bovine serum (FBS) purchased from Sigma Aldrich (Dorset,
UK), 100 units per mL penicillin, 100 μg mL−1 streptomycin,
and 250 ng mL−1 amphotericin B (PSA) (HyClone,
Cramlington, UK). F-12K contains 0.2 mM alanine, 0.6 mM
proline and has an osmolarity of 275 to 357 mOsm kg−1.
A549 cells were maintained in a humidified atmosphere of
5% CO2 and 95% air at 37 °C and the culture medium was
renewed every 3–4 days. The cells were subcultured every 7
days or before reaching 90% confluency. To subculture, cells
were dissociated using 0.25% trypsin plus 1 mM EDTA in
balanced salt solution (Gibco) and reseeded at 1.87 × 105 cells
per 175 cm2 cell culture flasks.
Cryopreservation of cell monolayers. Methods adapted
from Bailey et al.14 Cells to be frozen in monolayer format
were seeded at 0.4 × 106 (A549) or 0.5 × 106 (Neuro-2a, MC-
3T3) cells per well in 500 μL of cell culture medium in 24-
well plates (Corning Incorporated, Corning, NY). Plates had a
total available volume of 3.4 mL with an approximate growth
area of 1.9 cm2, no coverslips were used and plates were used
with the accompanying lid. Cells were allowed to attach to
the entire free surface of the bottom of the well and formed a
confluent layer not greater in height than one cell. Before
experimental treatments, cells were allowed to attach for 2 h
to the plates in a humidified atmosphere of 5% CO2 and
95% air at 37 °C. The medium was exchanged against
medium that was or was not supplemented with solutes as
indicated in the figures. Control cells received no additional
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solutes and experimental cells were incubated in indicated
solutions for 24 h in a humidified atmosphere of 5% CO2
and 95% air at 37 °C. Following the incubation period, the
culture medium was removed and cells were exposed for 10
min at room temperature to different concentrations of
solutes dissolved in base media supplemented with 10% FBS
and indicated concentrations of DMSO. After 10 min, the
freezing solutions were removed and the plate placed inside
a CoolCell® MP plate (BioCision, LLC, Larkspur, CA),
transferred to a −80 °C freezer and frozen at a rate of 1 °C
min−1. After 24 h at −80 °C, cells were rapidly thawed by
addition of 500 μL complete cell culture medium warmed to
37 °C. Cells were placed in a humidified atmosphere for 24 h
and then dissociated using 0.25% trypsin plus 1 mM EDTA
in balanced salt solution. The number of viable cells was
then determined by counting with a hemocytometer (Sigma
Aldrich) at room temperature after 1 : 1 dilution of the sample
with 0.4% trypan blue solution (Sigma Aldrich). The initial
cell medium was discarded such that any non-attached cells
were not included in the assessment. The percentage of
recovered cells was calculated by dividing the number of cells
with intact membranes after freezing and thawing by the
number of cells present prior to freezing (i.e. after application
of pre-treatments), multiplied by 100.
Post-freezing cell viability assay. Cells were seeded post-
thaw at 12.5 × 103 per well in 6-well plates in 2 mL of
complete cell media. Cells were placed in a humidified
atmosphere of 5% CO2 and 95% air at 37 °C and allowed to
grow, with counts starting on day two and ending on day six.
Cell media was renewed on day three. Cells were dissociated
using 0.25% trypsin plus 1 mM EDTA in balanced salt
solution. The number of viable cells was then determined by
counting with a hemocytometer at room temperature after 1 :
1 dilution of the sample with 0.4% trypan blue solution. Fold
increase of cells was calculated by dividing the number of
cells with intact cell membranes by the number of cells
initially plated.
Incubation growth assay. Cells were seeded at 12.5 × 103
per well in 6-well plates (Thermo Fisher) in 2 mL of complete
cell media or in the indicated solutions. Cells were placed in
a humidified atmosphere of 5% CO2 and 95% air at 37 °C
and allowed to grow, with counts starting on day two and
ending on day six. Cell media was renewed on day three.
Cells were dissociated using 0.25% trypsin plus 1 mM EDTA
in balanced salt solution. The number of viable cells was
then determined by counting with a hemocytometer (Sigma
Aldrich) at room temperature after 1 : 1 dilution of the sample
with 0.4% trypan blue solution (Sigma Aldrich). Fold increase
of cells was calculated by dividing the number of cells with
intact cell membranes by the number of cells initially plated.
Incubation recovery growth assay. Cells were seeded at
12.5 × 103 per well in 6-well plates (Thermo Fisher) in 2 mL
of complete cell media or in the indicated solutions. Cells
were placed in a humidified atmosphere of 5% CO2 and 95%
air at 37 °C and allowed to grow, with counts starting on day
four and ending on day six. Cell media was renewed on day
three and cells incubated in solutes were switched back to
complete cell media. Cells were dissociated using 0.25%
trypsin plus 1 mM EDTA in balanced salt solution. The
number of viable cells was then determined by counting with
a hemocytometer (Sigma Aldrich) at room temperature after
1 : 1 dilution of the sample with 0.4% trypan blue solution
(Sigma Aldrich). Fold increase of cells was calculated by
dividing the number of cells with intact cell membranes by
the average number of cells on day three from the incubation
growth assay.
Osmolyte incubation calcein/ethidium homodimer-1
uptake. A549 cells were seeded at 4 × 105 cells per well in 500
μL of cell culture medium in 24-well plates. Cells were
incubated with osmolyte solutions for 24 h in a humidified
atmosphere of 5% CO2 and 95% air at 37 °C. Following the 24 h
incubation, cells were incubated with 0.3 μM calcein-AM
(ThermoFisher) and 10 μM ethidium homodimer-1
(ThermoFisher) in PBS. Cells were incubated at room
temperature for 45 min in the dark. Solution was removed and
wells were washed twice with PBS. Plate was read using the
BioTex plate reader at 494/517 nm and 528/617 nm. Plate was
then imaged with a CKX41 microscope with pE-300-W LED
illumination, XC30 camera, and processed using CellSens
software.
Post-freeze membrane calcein/ethidium homodimer-1
uptake. A549 cells were cryopreserved as monolayers as
previously indicated. Following the 24 h post-thaw
incubation, cells were incubated with 0.3 μM calcein and 10
μM ethidium homodimer-1 in PBS. Cells were incubated at
room temperature for 45 min in the dark. Solution was
removed and wells were washed twice with PBS. Plate was
read using the BioTex plate reader at 494/517 nm and 528/
617 nm. Plate was then imaged with a CKX41 microscope
with pE-300-W LED illumination, XC30 camera, and
processed using CellSens software.
Physical and analytical methods
Differential scanning calorimetry. Samples were prepared
by weighing standard 40 μL aluminium crucibles (Mettler
Toledo, Leicestershire, UK) and adding 15 μL of analyte
before sealing and reweighing in order to quantify the exact
mass of sample. Each sample was then transferred to a liquid
nitrogen cooled DSC 1 STAR® system (Mettler Toledo,
Leicestershire, UK) differential scanning calorimeter. The
mass of the aluminium crucible and sample mass was input
into the complimentary STARe thermal analysis software to
retain a digital record and aid analysis. Each DSC sample was
individually cooled from +25 °C to −150 °C at a rate of 10 °C
min−1 whilst concurrently monitoring the heat flow (mW) of
the system to detect any endothermic or exothermic
transitions. When samples were cooled to −150 °C, each
sample was held for 10 min and then warmed at a rate of 10
°C min−1 from −150 °C to +25 °C. Raw data from each
experiment was exported and plotted in R (R Foundation for
Statistical Computing, Vienna, Austria) and individual peaks
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highlighted for comparison using the STARe thermal analysis
software built-in modelling functions for linear curve fitting
and area under the curve when required.
Ice recrystallization ‘splat’ assays. A 10 μL droplet of
compound in the indicated solution was dropped using a
Hamilton gastight 1750 syringe (Hamilton Bonaduz AG, GR,
Switzerland) from a fixed height of 1.4 m onto a 22 × 22 mm
no.1 glass cover slip (Fisher Scientific UK Ltd, Leicestershire,
UK) placed on a CO2(s) cooled aluminium plate (∼−70 °C).
The droplet froze instantly upon impact with the plate
forming a thin wafer of ice. This wafer was then placed on a
liquid nitrogen cooled BCS196 cryostage (Linkam Scientific,
Surrey, UK) and held at −8 °C to anneal for 30 min using the
LNP96 cooling system (Linkam Scientific). Photographs were
taken using a Canon EOS 500D SLR digital camera (Canon
(UK) Ltd, Surrey, UK) after 0 and 30 minutes coupled to an
Olympus CX41 microscope (Olympus, Southend-on-Sea, UK)
equipped with UIS-2 20×/0.45/∞/0–2/FN22, UIS-2 4×/0.1/∞/–/
FN22 and UIS-2 10×/0.2/∞/–/FN22 lenses (Olympus Ltd, Essex,
UK) through cross polarisers. The number of crystals in the
image was counted using ImageJ (version 1.52a)48 and the
area of the field of view divided by the number of crystals
gave the average crystal size per wafer.
Results and discussion
The main aim of this study was to explore the use, and
mechanisms, of proline as an additive to enhance the
cryopreservation of cell monolayers, in comparison to other
osmolytes. A second objective was to explore the synergy of
proline with ice recrystallization inhibitors (IRIs) which may
also aid cell monolayer cryopreservation. Betaine and alanine
were chosen as control osmolytes to be used throughout this
study. To evaluate if ice recrystallization inhibition (i.e.
preventing ice crystals from growth) occurs in the presence of
osmolytes the ‘splat assay’ was used.24,49 This was important,
as several studies have shown that the exact ions in solution
can impact IRI activity, and any subsequent cryopreservation
results can only be interpreted if this effect is known.50,51
The assay involves rapid nucleation of small (<10 μm) ice
crystals followed by annealing at −8 °C for 30 minutes. After
this time, the wafers were imaged and the size of the ice
crystals was assessed; smaller crystals mean more IRI activity,
Fig. 1A. For the osmolyte solutions, significantly smaller
crystal sizes than PBS alone were observed, yet all also had
significantly larger crystal sizes than 5 mg mL−1 PVA in PBS.
The data is summarized in Fig. 1B, as average crystal size.
Note, mean grain size (MGS), the standard measure52 is not
used as the large differences between conditions makes this
comparison challenging. It is important to observe that any
additive at sufficiently high concentration will slow ice
growth, and under these conditions the osmolytes alone
would not be considered IRI active.52
As high (>100 mM) concentrations of osmolytes will be
used in the cryopreservation studies, it was also essential to
investigate the impact osmolytes have on total ice formation
during cryopreservation conditions. Fig. 1C shows the total
enthalpy of crystallization (which is proportional to the total
volume of ice formed) for each osmolyte (in PBS), 10% DMSO
and with/without PVA as determined by differential scanning
calorimetry. When DMSO is used there is an expected
decrease in the enthalpy of crystallisation,53 but significant
ice is still forming, which confirms the conditions employed
here are not leading to vitrification (an alternative method of
cryopreservation). Full DSC traces for melting/freezing are
shown in Fig. S1 and S2.‡ These results demonstrate that the
osmolytes, at the concentrations used, do not significantly
impact the physical process of ice formation and growth,
which is essential to enable their biochemical roles (below)
to be investigated.
Following the above studies on ice formation/growth,
A549 (adenocarcinomic human alveolar basal epithelial) cells
were employed to test the cytotoxicity of each component,
after 24 hours exposure. PVA (polymeric ice recrystallization
inhibitor) led to a small reduction in metabolic activity (Fig.
S3‡), and there was no significant reduction for any of the
osmolytes (proline, betaine, alanine (Fig. S4‡)), and hence
cryopreservation studies could be conducted.
A549 cell monolayers were evaluated for cryopreservation
(using 10 vol% DMSO) with and without proline pre-
incubation (for 24 hours to allow time for pre-
conditioning14,34) and with variable concentrations of PVA as
the IRI active agent, Fig. 2A. This was to determine the
additive effect of proline when supplemented into standard
cryopreservation conditions. It is crucial to note at this point
that excess CPA solutions were removed before freezing, thus
allowing thawing by addition of pre-warmed media, which
also diluted any residual cryoprotectants while ensuring a
rapid thawing process. Cells were allowed to recover for 24
hours post-thaw before assessment of recovery. This is
important as shorter post-thaw times lead to false positives if
cells are evaluated before apoptotic processes have had a
chance to complete.13,54 Therefore the number presented is
the number of cells after 24 hours, relative to those prior to
freezing, and hence includes some time for potential cell
growth, but remains a robust measure to avoid over-
estimation if shorter times to assay are used.
Cryopreservation of A549 cell monolayers in 10% DMSO
alone lead to <25% cell recovery, compared to >60% which is
achieved in suspension cryopreservation of A549 cells,55
highlighting the significant challenge of directly cryopreserving
cells in this format and the need for disruptive technologies. In
contrast to the DMSO only conditions, pre-incubation with
proline for 24 hours increased the post-thaw recovery to ∼50%,
which is a remarkable increase and in line with previous
observations of proline-mediated cryopreservation.14 Additional
pre-incubation periods were not evaluated so the potential for
further optimisation exists. Addition of PVA, to reduce ice
recrystallization, further increased recovery to 60% recovery
using 2–5 mg mL−1. Higher concentrations of PVA had no
further benefit, as has been previously reported.21,31
Interestingly, without the proline pre-incubation, PVA did not
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have significantly positive effects on post-thaw recovery,
supporting a hypothesis that ice recrystallization is a problem
in cell monolayer storage, but that other damage mechanisms
are more significant and must be mitigated first.
To gain further insight, the thawed A549 cells were
isolated and re-plated at 12.5 × 103 cells per well and their
growth rate measured over 6 days. Fig. 2B shows that cells
that had been pre-incubated with proline lead to faster
growth rates compared to cells without. This shows that not
only are more cells recovered, but that they are more viable
due to the action of proline. In contrast, PVA increased the
number of cells but had no impact on cell growth rate, and
hence shows the polymer only has biophysical, not
biochemical, function and shows synergistic protective
Fig. 1 Impact of cryoprotectants on ice formation and growth. A) Example ice wafers from ‘splat assay’ following annealing for 30 minutes; i)
PBS, ii) 100 mM alanine in PBS, iii) 100 mM betaine in PBS, iv) 200 mM proline in PBS, v) 5 mg mL−1 PVA in PBS, vi) 100 mM alanine/5 mg mL−1 PVA
in PBS, vii) 100 mM betaine/5 mg mL−1 PVA in PBS, viii) 200 mM proline/5 mg mL−1 PVA in PBS. Scale bar = 100 μm. B) Average ice crystal sizes
determined from splat test. *P < 0.0001 from PBS. **P < 0.0001 from 5 mg mL−1 PVA in PBS. Note: average crystal size is not reported as a % of
PBS (which is standard) to allow for statistical comparisons. All error bars represent ± SEM of 3 independent experiments, dots indicate individual
data points. C) Average enthalpy of ice crystallisation determined by DSC. *P < 0.0001 from PBS. **P < 0.001 from 10% DMSO (100 mM proline
(standards) N = 2 and was not included in statistical assessment). All error bars represent ± SEM of 3 independent experiments, dots indicate
individual data points.
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mechanisms are in action. Two other cells lines were also
explored, (MC-3T3 and Neuro-2a) where smaller effects were
observed which may be due to specific cell differences
including size but also their response to hypotonic
conditions and contact inhibition (Fig. S5‡). This observation
is crucial to highlight how the cell type and format
(suspension verses monolayer, freezing rates, etc.) all have
major impacts on cryopreservation outcomes and suggests
there may not be ‘one size fits all’ solutions.
The above data shows that proline had a significant
benefit for monolayer cryopreservation, and that recovered
cells grew faster, at a rate closer to healthy non-frozen cells.
To understand if proline's activity was simply due to it being
an osmolyte, or if it had (for example) pre-conditioning
effects,56 betaine and alanine were used as control osmolytes.
A549 cells were pre-incubated with the osmolytes for 24
hours, then cryopreserved with 5 mg mL−1 PVA + 10% DMSO.
Post thaw, the number of cells was determined after 24 hours
culture. In the case of betaine, maximum cell recovery was
observed with 100 mM, with PVA giving some benefit to cell
recovery at all betaine concentrations (Fig. 3A). Alanine
showed no significant increase in post-thaw recovery
compared to control cells (Fig. 3B). All cells frozen with
betaine or alanine, with or without PVA, grew faster post-
freeze than cells frozen with only 10% DMSO (Fig. 3C).
Betaine's osmoprotection has been previously studied,41 and
attributed to the osmoregulated betaine/GABA transporter
(BGT1) which couples the transport of betaine to Cl− and Na+
across the cell membrane.57,58 Renomedullary cells grown in
hyperosmotic media contained higher concentrations of
betaine than cells grown in isotonic media59 and simian-
virus-40-transformed Balb/c 3T3 (SV-3T3) cells were resistant
to osmotic stress, which typically resulted in inhibition of
protein synthesis and decreased proliferation, when treated
exogenously with betaine.60 Taken together this data shows
that proline and betaine have preferential roles in
cryopreservation, as this is not simply an effect of added
solutes or osmolarity, and are potent additives for cell
monolayer cryopreservation. It is, however, not clear if
betaine and proline afford their protection via the same
mechanisms.
To gain more insight into how each osmolyte functions,
growth curves for the cells were monitored as this provides a
more rigorous evaluation of health than single point viability
measures. Two sets of conditions were evaluated here (Fig. 4)
using the concentrations of each osmolyte which gave
maximal cell recovery (from Fig. 2 and 3). Firstly, cells were
cultured over 6 days in the presence of osmolytes to allow
their effects on overall cell growth to be monitored. This
experiment is distinct from cytotoxicity assays, in that cells
are seeded at low densities so they have space to propagate.
Secondly, cells were incubated with osmolytes for 3 days,
then exchanged for cell media, and allowed to recover for 3
more days.
When cells were cultured for 6 days in the presence of the
osmolytes (at their optimised concentration), proline showed
suppression of the growth rate compared to control cells and
other osmolytes, which would imply proline has a growth-
limiting impact on the cells (Fig. 4A). Next, the cells were
incubated with the osmolytes for 3 days, and then the media
replaced with standard (no osmolyte) growth media. The
proline-treated cells showed a higher fold change in growth rate
than other conditions, including control cells, and while the R2
value is lower than control values, it does trend upwards
(Fig. 4B). This data shows that proline causes a short-term
down-regulation in proliferation, which is rapidly recovered
when proline is removed. P493 (B lymphoma) cells incubated in
proline have been shown to have growth inhibition, and thus,
resulted in the proline biosynthesis (PB) pathway being down-
regulated with a downstream effect on the glycolytic pathway.61
This suggests that the lower proliferation rate seen here may
not be the proline itself, but rather the effects of the PB pathway
Fig. 2 Impact of proline on post-thaw recovery and growth of A549
monolayers after cryopreserving at −80 °C. A) Total cell recovery 24
hours post thaw, determined via trypan blue assay. Error bars represent
± SEM of 3 independent experiments with two nested replicates. *P <
0.00001 from control (0 mg mL−1 in F-12K). B) Growth rate of A549
cell monolayers post-thaw. Shaded area represents standard error of 3
independent experiments. R2 values are indicated.
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not running due to an increase in the available free proline.
This down-regulation in growth may be partially responsible for
the cryoprotection seen with proline, as metabolic depression
Fig. 3 Impact of alanine and betaine on post-thaw recovery and
growth of A549 monolayers after cryopreservation at −80 °C. A) Total
cell recovery 24 hours post thaw with betaine as osmolyte, recovery
determined via trypan blue assay. *P < 0.00001 from control (0 mg
mL−1) with no PVA, **P < 0.0001 from control with 5 mg mL−1 PVA. B)
Total cell recovery 24 hours post thaw with alanine as osmolyte,
recovery determined via trypan blue assay. Error bars represent ± SEM
of 3 independent experiments with two nested replicates, dots indicate
individual data points. C) Post-thaw growth rates of A549 cell
monolayers. Shaded area represents standard error of 3 independent
experiments (100 mM alanine N = 2).
Fig. 4 Impact of osmolytes on non-cryopreserved A549 cell
monolayers. A) Growth rates during incubation with F-12K or osmolyte
for 6 days. *P < 0.0002 from control. B) Growth rates after incubation
with osmolyte for 3 days, then replacing media with F-12K media for 3
days (hence data starts on day 4). *P < 0.02 from control. Shaded area
represents standard error of 3 independent experiments. Plate maps
show experimental design, where cells are seeded, what treatment
they received, and the day when cells are removed (for counting)
indicated.
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and cell stasis are often prerequisites to survival for organisms
with natural adaptations to desiccation, freezing temperatures,
and anoxia.62 For example, pretreatment with
5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside (AICAR)
can increase cell yields post-thaw, potentially due to metabolic
down-regulation (e.g. diapause56).
To gain mechanistic insight into the role of proline in
cryopreservation, membrane permeabilisation assays were
undertaken. Fig. 5A shows results of live/dead staining on
A549 cell monolayers after incubation with the osmolytes
(green indicates intact membranes, red indicated
permeability). In all cases, there was no significant change in
membrane permeable (red) cells compared to the controls of
media alone (Fig. S6‡). The same assay was undertaken on
cryopreserved cells (Fig. 5B) which had been pre-incubated
with osmolytes. Minimal differences were seen for
cryopreserved cells in any of the osmolyte conditions, with or
without PVA, compared to cells frozen with 10% DMSO (Fig.
S7‡). This is contrary to the cell recovery data in Fig. 2 and 3,
which showed that PVA plus proline or betaine gave higher
recovery values than 10% DMSO alone. This suggests that
whilst the cryopreserved cells appear to be functionally
similar, only cells incubated with proline or betaine and
cryopreserved with PVA were able to survive the stress of the
subsequent trypsinisation step prior to cell recovery analysis.
The above data shows that proline has a privileged role in
cryopreservation of cell monolayers and acts to slow the
growth rate of cells preparing them for cryopreservation
without affecting their post-thaw growth rate. This effect is
more pronounced than for other osmolytes, and there is no
evidence that this is a biophysical process. It is important to
again highlight the differential responses seen with other cell
lines (Fig. S5‡) to proline pre-incubation. The biochemical
mode of action is supported by this differential response and
the data presented here does not rule out the use of proline
for other cells lines. Further exploration of the large
formulation space of concentrations, timings, and cell
densities may show a benefit, but highlights that if pre-
conditioning (or related strategy) is to be deployed, each line
may need individual optimisation. To provide addition
insight, whole cell proteomics was undertaken to search for
any specific process which might underpin these
observations. A549 cells were incubated with the osmolytes
for 24 h and then subjected to whole cell proteomic analysis,
compared to control cells with the osmolytes. After sample
normalisation, 5516 proteins were identified and quantified
with a Pearson correlation coefficient >0.99 for all samples
(Fig. S8‡). Volcano plots show the distribution of significantly
regulated proteins when alanine, proline, and betaine
incubated cells were compared against control cells. Gene
ontology category Fisher exact test enrichment showed a
significant enrichment among the regulated proteins located
in the nucleus and membrane when alanine and control
conditions were compared. Similar analysis significantly
enriched the plasma membrane components when the
proline supplemented media was compared to the control
(Fig. 6).
Fig. 6 shows that alanine led to more up/down regulation
than either proline or betaine, despite resulting in a minimal
effect on cryopreservation outcome, compared to the other two
osmolytes. Summaries of up/down regulated proteins are shown
in the ESI‡ (Fig. S9–S11 and Table S1). For the betaine treated
cells, there were 5 significantly different proteins. Upregulation
of CALCOCO2 was seen, an effector for clearing bacteria63 with
implications in cytoskeleton organization,64 and upregulation
was also seen with proline-incubated cells; CIRBP, a cold-
inducible protein implicated in the suppression of cell
proliferation;65 PTRH1, a t-RNA hydrolase;66 and GPCPD1, a
glycerophosphocholine phosphodiesterase.66 Downregulation
was seen for TGFB2, a transforming growth factor beta-2
proprotein, a multifunctional protein that regulates numerous
processes. With regard to the proline treated cells, there were
Fig. 5 Membrane permeability assays of A549 cells using calcein (green-live)/EthD-1 (red-dead) staining. A) Cells incubated in osmolyte solutions
for 24 h then imaged. B) Membrane permeability of frozen/thawed cells which had been previously incubated with indicated osmolyte (or media)
and cryopreserved in 10% DMSO (±PVA). Scale bar = 50 μm.
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no clear single up/down regulated proteins which would allow
assignment of the biochemical basis of protection, but there
were some regulated proteins which could be important and are
summarised here. The upregulation seen for the histone RNA
hairpin-binding protein (SLBP) may be due to the increase in
HIST1H4A and H1F0 as an increase in histones may result in
an increase in the protein involved in the processing,
translation, and degradation for the mRNAs of histones.67 There
was a significant reduction in both SLBP and H1F0 in cells
treated with alanine, further suggesting the expression of these
proteins is linked. Upregulation in SERPINE1 may provide
protection via “wound healing” for cells in a monolayer,68 as
this protein would not be expected to be involved in replicative
senescence for A549 adenocarcinoma cells as this process
protects against oncogenic transformation and requires
integrity of the p53 tumour suppressor pathway.69–71
Interestingly, TUT1, a biosensor for the transduction of stress
signals within the cell nucleus and also an effector for the fate
of target mRNAs,72 was shown to be upregulated in proline
treated cells but downregulated in cells treated with alanine.
Pathway enrichment analysis for proline showed that
general stress responses are the most frequent changes,
suggesting this osmolyte has a broad function on cells which
could lead to the observed cryopreservation benefits (Table 1).
Proline has been implicated as a survival factor that protects
the cell against apoptosis and maintains the progression of
the cell cycle.44 This proteomics study identified the cell
nucleus and membranes as the principal cell components
affected by our treatments and highlighted some stress
responses as potential candidates to explain our previous
observations in proline pre-treated cells and their enhanced
cryopreservation outcomes. This is not intended as a full
description of the cells state, but rather to help guide future
research in this area to fully understand the biological impact
of this pre-conditioning. This may include focusing on some
of the candidates described here to identify a target/effect to
further explain proline's function and it may be possible to
discover target molecules or pathways to help prepare cells
for low temperatures, and hence, increase cell yields.
Conclusions
Here we have explored the role that proline plays in improving
the cryopreservation outcomes of cell monolayers, which
Fig. 6 Volcano plots illustrate significantly regulated proteins in A549 cells incubated with A) alanine, B) proline, or C) betaine compared with the
control condition. All conditions have been tested in at least quadruplicates. The –log 10 (Welch's T-test P value) is plotted against the log 2 (fold
change as indicated in the X axes). The solid black, blue, and red dots represent the significantly regulated proteins (Welch's test, FDR < 0.01 and
S0 = 0.1). The dot colours indicate the most abundant enriched gene ontology cellular compartment (GOCC) categories among the significantly
regulated proteins according to the Fisher exact test (FDR < 0.0001).
Table 1 Pathway enrichment analysis of significantly regulated proteins in A549 cells incubated with proline
Pathway name Entities found Entities total
Apoptosis induced DNA fragmentation 1 13
Cellular responses to stress 8 690
Death receptor signalling 3 157
FGFR2b ligand binding and activation 1 14
TNFR-1-induced proapoptotic signalling 1 14
Chylomicron assembly 1 14
Dissolution of fibrin clot 1 14
Autophagy 3 160
Data analysed online with Reactome open access pathway database. FDR (false discovery rate) = 2.62 × 10−1.
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currently are very challenging to store frozen and result in low
cell recovery rates, compared to suspension cryopreservation.
The yield of A549 cell monolayers increased from below 25% to
∼50% by supplementation of proline or betaine, which was
further increased to 60% by addition of the polymeric ice
recrystallization inhibitor PVA. Without the osmolyte pre-
incubation, the PVA had no impact. This demonstrates that IRI
is useful to enhance cryopreservation, but other (more
significant) sources of cryo-damage must be first mitigated. Post-
thaw growth rates of proline and betaine treated cells were also
closer to non-frozen controls than other conditions, confirming
the beneficial role. It was also observed that other cell lines do
not respond in the same manner to the proline treatment,
suggesting individual optimisation is required. To understand
the impact of the pre-freeze incubation, cell growth rates were
examined in the presence of osmolytes. It was shown that cell
growth rates were significantly suppressed with proline added,
but quickly recovered if the media was exchanged, supporting a
hypothesis that proline pre-conditions the cells by slowing
growth and preparing the cells for cold stress and agrees with
observations that some extremophiles upregulate proline
biosynthesis in anticipation of cold stress. Whilst betaine also
improved cryopreservation outcomes it did not have the same
downregulation on cellular growth rates, providing more
evidence that the mechanism of action for proline is unique.
Membrane stability assays showed that proline did not impact
cell membrane permeability compared to control cells or other
osmolytes, and biophysical assays of ice formation/growth also
confirm that proline had no biophysical role, and hence its
function is purely biochemical. Whole cell proteomics were used
to explore protein regulation but did not show conclusively any
single pathway which could be attributed to this effect. However,
when cells were incubated in proline, the upregulation of key
histone proteins was observed (which were downregulated in
our alanine samples), along with upregulation of stress and
membrane proteins, with lipid and proliferation proteins being
downregulated, which may be crucial to proline's role but will
require further investigation.
Overall this data provides further evidence that pre-
conditioning of cell monolayers is a powerful tool to improve
post-thaw cell yields, and that proline is an accessible and
biocompatible additive that can easily be added into existing
protocols. It also suggests that small molecule modulators of
cryopreservation could be discovered if the pathways acted upon
by proline can be fully elucidated, enabling a chemical biology
driven approach towards the discovery of cryoprotective agents/
modulators. These findings will help guide processes for
improved monolayer storage techniques with subsequent
benefits in drug screening, basic research, and improvement for
frozen distribution of cells and cell products.
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